Superselective
administration

Implanting the right type of stem cells as close to the affected region of the body is our specialty. For years we have made an active effort to develop propritory safe and effective implantation procedures

Read more

A natural regenerative
alternative

Stem cells enable our body to repair itself. We research the regeneration potential of various cell types and discover super-selective routes of administration for their complete utilisation.

Read more

Our Caribbean
research center

With new pastures, come new possibilities. A venue closer to North America, opening doors for new research that wasn't possible before. An institution focused on superior objective followup, directly by our clinicians.

Read more

Scientific legacy
to the world

Almost a decade of our work is a result of supportive governance over stem cell research in India. While many countries are now opening up to the idea, we collaboratively work with international groups to make our products easily available

Read more

Improving lives
with stem cells

Stem cells hold a promising future for countering many incurable diseases by repairing organ tissue instead of providing temporary relief from conventional medication.

Read more

Developing regenerative medicine and their superselective administration protocols

Almost a decade of research on regenerative medicine and its applications in the treatment of auto-immune and incurable chronic disorders.
We collaboratively function to bring medical, biological and technological expertise together to innovate therapeutic medical products aimed to replace degenerating, inflamed and weak tissue with renewed healthy tissue in order to halt and reverse disease symptoms and to restore the adversely affected functions of the human body.

Welcome!

Here, we will help you find information about our work with stem cells and therapeutic applications

First of all, we thank you for taking the time to look at our website. If you're a patient, researcher, doctor or just another curious human being trying to get more information on our stem cell treatments, we are here to help..

Read more

About us

Introducing our group of researchers and clinicians who work tirelessly behind the scenes.

Here's to the founders and to all who have contributed in the development of the very methods of isolating the perfect cell lines and developing the superselective administration routes that have helped many patients to date.

Read more

Upcoming & ongoing comprehensive stem cell clinical trials

01

An open-label, non-randomized, phase I/II study of allogeneic human umbilical cord tissue-derived mesenchymal stem cells (UC-MSC) and liberation therapy (when associated with chronic cerebrovascular venous insufficiency) in patients with relapsing remitting multiple sclerosis (RRMS).

02

An open-label, non-randomized, phase I/II study of autologous bone marrow-derived mononuclear fraction of stem cells (BM-MNC) and liberation therapy (when associated with chronic cerebrovascular venous insufficiency) in patients with relapsing remitting multiple sclerosis (RRMS).

03

A study to rebuild baseline and current patient data for comparison with data collected in scheduled followups to be conducted and sponsored by Genesis for the establishment of subjective end points to gauge efficacy. The follow-up study application awaits IECP review and approval.